Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M MacCollin

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Brain & Development|July 1, 1995
CNS Young Investigator Award Lecture: molecular analysis of the neurofibromatosis 2 tumor suppressorM MacCollin
Current Opinion in Neurology|March 23, 2001
Molecular genetic aspects of the phakomatoses: tuberous sclerosis complex and neurofibromatosis 1M MacCollin, D Kwiatkowski
Seminars in Pediatric Neurology|January 6, 1999
The diagnosis and management of neurofibromatosis 2 in childhoodM MacCollin, V F Mautner
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 5, 2001
Establishing priorities in neurofibromatosis research: a workshop summaryM MacCollin, D H Gutmann, B Korf, et al.
Neurology|April 1, 1996
Schwannomatosis: a clinical and pathologic studyM MacCollin, W Woodfin, D Kronn, et al.
Neurology|May 9, 2001
Monocular elevator paresis in neurofibromatosis type 2R A Egan, C R Thompson, M MacCollin, et al.
Current Opinion in Genetics & Development|February 1, 1996
Neurofibromatosis 2: loss of merlin's protective spellJ F Gusella, V Ramesh, M MacCollin, et al.
Journal of Neurochemistry|January 1, 1996
Characterization and expression of the human A2a adenosine receptor geneR A Peterfreund, M MacCollin, J Gusella, et al.
Biochimica Et Biophysica Acta|April 24, 1999
Merlin: the neurofibromatosis 2 tumor suppressorJ F Gusella, V Ramesh, M MacCollin, et al.
JAMA|November 17, 1993
DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigreeM MacCollin, T Mohney, J Trofatter, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Brain & Development|July 1, 1995
CNS Young Investigator Award Lecture: molecular analysis of the neurofibromatosis 2 tumor suppressorM MacCollin
Current Opinion in Neurology|March 23, 2001
Molecular genetic aspects of the phakomatoses: tuberous sclerosis complex and neurofibromatosis 1M MacCollin, D Kwiatkowski
Seminars in Pediatric Neurology|January 6, 1999
The diagnosis and management of neurofibromatosis 2 in childhoodM MacCollin, V F Mautner
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 5, 2001
Establishing priorities in neurofibromatosis research: a workshop summaryM MacCollin, D H Gutmann, B Korf, et al.
Neurology|April 1, 1996
Schwannomatosis: a clinical and pathologic studyM MacCollin, W Woodfin, D Kronn, et al.
Neurology|May 9, 2001
Monocular elevator paresis in neurofibromatosis type 2R A Egan, C R Thompson, M MacCollin, et al.
Current Opinion in Genetics & Development|February 1, 1996
Neurofibromatosis 2: loss of merlin's protective spellJ F Gusella, V Ramesh, M MacCollin, et al.
Journal of Neurochemistry|January 1, 1996
Characterization and expression of the human A2a adenosine receptor geneR A Peterfreund, M MacCollin, J Gusella, et al.
Biochimica Et Biophysica Acta|April 24, 1999
Merlin: the neurofibromatosis 2 tumor suppressorJ F Gusella, V Ramesh, M MacCollin, et al.
JAMA|November 17, 1993
DNA diagnosis of neurofibromatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigreeM MacCollin, T Mohney, J Trofatter, et al.
Pageof 5